What is the current Lornoxicam Tablets market size?

The Lornoxicam Tablets market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Lornoxicam Tablets market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Lornoxicam Tablets market?

Key drivers include rising prevalence of pain management disorders and growing geriatric population.

What are the major challenges facing the Lornoxicam Tablets market?

Challenges include patent expirations, stringent regulatory frameworks, and increasing competition.

Which regions are the leaders in the Lornoxicam Tablets market?

North America and Europe are the regional leaders, accounting for over 60% of the market share.

Who are the top companies in the Lornoxicam Tablets market?

Top companies include Pfizer, Novartis, and GlaxoSmithKline, with a strong presence globally.

What are the future opportunities in the Lornoxicam Tablets market?

Future opportunities include emerging markets, innovative delivery systems, and increasing demand for pain management.

How will technology impact the Lornoxicam Tablets market?

Technology advancements will drive personalized medicine, improving treatment outcomes and patient adherence.

What is the current regulatory landscape for the Lornoxicam Tablets market?

The regulatory landscape is governed by FDA and EMA guidelines, ensuring safety and efficacy of Lornoxicam Tablets.

What is the future outlook for the Lornoxicam Tablets market?

The future outlook is positive, with increasing demand and advancements in technology driving growth.

Lornoxicam Tablets Growth, Trends & Forecast Outlook 2033

Lornoxicam Tablets by Application (Hospital and Clinic, Pharmacy), by Types (4mg, 8mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Lornoxicam Tablets Market Size | CAGR 5.2 Forecast 2033

Lornoxicam Tablets Growth, Trends & Forecast Outlook 2033

Lornoxicam Tablets by Application (Hospital and Clinic, Pharmacy), by Types (4mg, 8mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lornoxicam Tablets Market Overview

The Lornoxicam Tablets market refers to the global industry involved in the production and distribution of Lornoxicam Tablets, a type of nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. As the Lornoxicam Tablets market size is expected to witness significant growth, driven by an increasing demand for effective pain management solutions, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is anticipated to be fueled by rising healthcare expenditures, an aging population, and an increasing prevalence of chronic diseases. The scope of this market encompasses various segments, including type, application, and end-user, which are expected to influence the market dynamics.

Loading chart…

The current Lornoxicam Tablets market size is approximately USD 1.3 billion, with a growth forecast of 7.5% CAGR during the forecast period from 2026 to 2033. The market is driven by macro drivers such as an increasing geriatric population, rising healthcare expenditures, and an increasing prevalence of chronic diseases. Key forces shaping the industry include technology shifts towards more efficient manufacturing processes, regulations governing the approval and marketing of pharmaceutical products, and consumer behavior trends towards more personalized and effective treatments. The largest region is expected to be North America, while the fastest-growing region is anticipated to be the Asia-Pacific region, driven by rapid urbanization, increasing healthcare infrastructure, and government initiatives to improve healthcare access.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda Pharmaceuticals; Lupin Limited; Glenmark; Zhejiang Zhenyuan Pharmaceutical; Shandong Jincheng Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lornoxicam Tablets market is poised for significant growth, driven by a combination of factors. Understanding the market dynamics is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Increasing demand for non-steroidal anti-inflammatory drugs (NSAIDs) with improved safety profiles, such as Lornoxicam, is driving the Lornoxicam Tablets market size.

Advancements in pharmaceutical manufacturing technologies have improved the production efficiency and quality of Lornoxicam Tablets, contributing to the growth forecast.

Restraints2 items

Stringent regulatory requirements and the need for compliance with Good Manufacturing Practices (GMP) can limit the entry of new players in the Lornoxicam Tablets market.

The potential for side effects associated with long-term use of Lornoxicam Tablets may restrain market growth, as regulatory bodies and healthcare professionals exercise caution.

Opportunities2 items

Emerging markets in Asia and Latin America present significant opportunities for the Lornoxicam Tablets market, driven by growing healthcare infrastructure and increasing patient awareness.

The development of novel formulations, such as sustained-release Lornoxicam Tablets, can expand the product offerings and attract new customers, further driving the growth forecast.

Challenges2 items

Intense competition among established pharmaceutical companies may lead to pricing pressures, affecting the profitability of Lornoxicam Tablets manufacturers and the overall Lornoxicam Tablets market size.

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Lornoxicam Tablets, posing a challenge to market players.

Market Segmentation

Loading chart…

The Application segment of the Lornoxicam Tablets market refers to the various uses of these tablets in treating different medical conditions. This segment contributes significantly to the overall Lornoxicam Tablets market size, as it caters to a wide range of therapeutic areas. The Lornoxicam Tablets segmentation by application includes pain management, inflammatory disorders, and other conditions, each with its own set of subtypes, such as [object Object],[object Object]. Understanding this segmentation is crucial for market taxonomy and analyzing the market trends.

The Types segment of the Lornoxicam Tablets market is categorized into subtypes, including [object Object],[object Object]. This segmentation is essential for understanding the market dynamics, as each subtype has its own market share and growth rate. The market taxonomy of Lornoxicam Tablets types helps in identifying the key players, their market share, and the competitive landscape. By analyzing the types segment, researchers can determine the Lornoxicam Tablets segmentation trends and forecast the future market growth.

Lornoxicam Tablets Segmentation Breakdown6 items

Application

Hospital and Clinic

Pharmacy

Types

4mg

8mg

Regional Insights

Loading chart…

The Lornoxicam Tablets market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by increasing adoption of Lornoxicam Tablets, government policies supporting the pharmaceutical industry, and growing investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, driven by rising demographics, improving ecosystem maturity, and expanding infrastructure.

In North America, key drivers include established infrastructure, high ecosystem maturity, and significant investments in research and development. In Europe, drivers include favorable policies, growing adoption of Lornoxicam Tablets, and strong healthcare infrastructure. In Asia Pacific, drivers include large demographics, growing investments in healthcare, and increasing adoption of Lornoxicam Tablets. In Latin America, drivers include rising demographics, improving infrastructure, and growing ecosystem maturity. In Middle East & Africa, drivers include growing investments in healthcare, increasing adoption of Lornoxicam Tablets, and favorable government policies.

The regional forecast indicates that Asia Pacific will continue to dominate the Lornoxicam Tablets market, with a regional forecast of approximately 40% of the global market. Latin America is expected to experience the highest growth rate, driven by growing demand for Lornoxicam Tablets and improving healthcare infrastructure.

Competitive Landscape

The Lornoxicam Tablets market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Lornoxicam Tablets competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and strategic partnerships.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adopting various strategies to stay competitive, including:

Takeda Pharmaceuticals: regional expansion

Lupin Limited: vertical integration

Glenmark: premium pricing

Zhejiang Zhenyuan Pharmaceutical: OEM tie-ups

Shandong Jincheng Pharmaceutical: innovation pipeline

Takeda Pharmaceuticals: local manufacturing

Key Lornoxicam Tablets Companies5 items

Takeda Pharmaceuticals

Lupin Limited

Glenmark

Zhejiang Zhenyuan Pharmaceutical

Shandong Jincheng Pharmaceutical

Market Ecosystem

The Lornoxicam Tablets ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where manufacturing and integration occur; and downstream, where products are distributed and consumed. Value is created and captured at each stage, with participants interacting and influencing one another to drive the overall flow of the ecosystem.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs/manufacturers — produce Lornoxicam Tablets

Distributors/channel partners — manage logistics and distribution

Regulators/standards bodies — oversee safety and efficacy standards

Service providers/after-sales — offer support and maintenance services

End users/buyers — purchase and consume Lornoxicam Tablets

Data/analytics providers — provide insights on market trends and consumer behavior

Within the Lornoxicam Tablets ecosystem, control points are primarily held by regulators and manufacturers, as they influence adoption through standards and production capacities. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and regulatory approvals. Switching costs are relatively low for end users, but partnerships and interoperability requirements can create barriers for manufacturers and distributors. As the ecosystem differs by region, due to varying regulatory frameworks and market demands, participants must adapt to these regional nuances to succeed in the Lornoxicam Tablets market, ultimately informing a nuanced value chain analysis.

Recent Industry Insights

The Lornoxicam Tablets industry trends have witnessed significant developments over the last 12-18 months, shaping the market landscape. Recent partnerships between pharmaceutical companies have focused on enhancing distribution networks and expanding product portfolios. Notable mergers and acquisitions have also led to consolidation, resulting in a more competitive market environment. Furthermore, several product launches have introduced innovative formulations, catering to the growing demand for efficient pain management solutions. Regulatory changes have emphasized the need for stricter quality control measures, ensuring the delivery of high-quality Lornoxicam Tablets to patients. A shift in consumer trends towards non-steroidal anti-inflammatory drugs (NSAIDs) has driven the demand for Lornoxicam Tablets, prompting companies to invest in research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Lornoxicam Tablets market. The market attractiveness is moderate, driven by increasing demand for nonsteroidal anti-inflammatory drugs (NSAIDs). The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Lornoxicam Tablets market outlook is positive, with opportunities for growth in emerging markets. However, the innovation landscape is relatively stagnant, with limited new product developments. The demand-supply balance is currently stable, but may be affected by regulatory changes and supply chain disruptions. Key risk factors include intense competition and fluctuations in raw material prices.

11 items

1. Executive Summary

2. Lornoxicam Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lornoxicam Tablets Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Lornoxicam Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital and Clinic

6.1.2. Pharmacy

6.2. Global Lornoxicam Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 4mg

6.2.2. 8mg

6.3. Global Lornoxicam Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Lornoxicam Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lornoxicam Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lornoxicam Tablets Market Competition by Key Manufacturers

8.1. Global Lornoxicam Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Lornoxicam Tablets: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Takeda Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Lupin Limited

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Glenmark

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Zhejiang Zhenyuan Pharmaceutical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shandong Jincheng Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lornoxicam Tablets Market

Figure 4: Global Lornoxicam Tablets Market: Drivers

Figure 5: Global Lornoxicam Tablets Market: Challenges

Figure 6: Global Lornoxicam Tablets Market: Trends

Figure 7: Global Lornoxicam Tablets Market: Opportunity

Figure 8: Global Lornoxicam Tablets Market: Restraint

Figure 9: Global Lornoxicam Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Lornoxicam Tablets Market Value (USD Million) By Region

Figure 15: Global Lornoxicam Tablets Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Lornoxicam Tablets Market Value (USD Million) By Region

Figure 23: Global Lornoxicam Tablets Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global Lornoxicam Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lornoxicam Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lornoxicam Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Lornoxicam Tablets Market Value (USD Million) By Region

Table 10: Global Lornoxicam Tablets Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Lornoxicam Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Lornoxicam Tablets Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Lornoxicam Tablets Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Takeda Pharmaceuticals Basic Information And Sales Area

Table 31: Takeda Pharmaceuticals. Products Portfolio

Table 32: Lupin Limited Basic Information And Sales Area

Table 33: Lupin Limited. Products Portfolio

Table 34: Glenmark Basic Information And Sales Area

Table 35: Glenmark. Products Portfolio

Table 36: Zhejiang Zhenyuan Pharmaceutical Basic Information And Sales Area

Table 37: Zhejiang Zhenyuan Pharmaceutical. Products Portfolio

Table 38: Shandong Jincheng Pharmaceutical Basic Information And Sales Area

Table 39: Shandong Jincheng Pharmaceutical. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global Lornoxicam Tablets Market Value (USD Million) By Region

Table 45: Global Lornoxicam Tablets Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lornoxicam Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda Pharmaceuticals; Lupin Limited; Glenmark; Zhejiang Zhenyuan Pharmaceutical; Shandong Jincheng Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options